![Kalle Känd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kalle Känd
Algemeen Directeur bij Munir Sukhtian Pharmaceuticals
Profiel
Kalle Känd is currently the Chief Executive Officer at Munir Sukhtian Pharmaceuticals since 2020.
Prior to this, he held positions such as Chairman-Supervisory & Management Board at Acino Supply AG, Vice Chairman-Supervisory Board at Acino AG, and Chief Commercial Officer at Acino International AG from 2014 to 2016.
Dr. Känd obtained a doctorate degree from the University of Tartu.
Actieve functies van Kalle Känd
Bedrijven | Functie | Begin |
---|---|---|
Munir Sukhtian Pharmaceuticals
![]() Munir Sukhtian Pharmaceuticals Pharmaceuticals: MajorHealth Technology Munir Sukhtian Pharmaceuticals engages in the manufacturing and distribution of pharmaceuticals. It undertakes marketing and branding of products for infections, obstetrics, gynecology and urinary tract disorders, and cardiovascular and musculoskeletal diseases. The company was founded in 1989 and is headquartered in Amman, Jordan. | Algemeen Directeur | 06-03-2020 |
Eerdere bekende functies van Kalle Känd
Bedrijven | Functie | Einde |
---|---|---|
Acino AG
![]() Acino AG Pharmaceuticals: MajorHealth Technology Acino AG engages in the development and manufacture of pharmaceutical products. It also offers services such as registration, procurement, contract manufacturing, packaging, and logistics. Its products include solid oral dosage forms, patches, as well as biodegradable and subcutaneous implants. The company was founded by Wilfried Fischer in 1997 and is headquartered in Miesbach, Germany. | Directeur/Bestuurslid | - |
Acino Supply AG
![]() Acino Supply AG Pharmaceuticals: MajorHealth Technology Acino Supply AG engages in the development, manufacture, purchase, and distribution of pharmaceutical products. It also coordinates all related activities. The company was founded on January 23, 2006 and is headquartered in Aesch, Switzerland. | Algemeen Directeur | - |
ACINO HOLDING AG | Algemeen Directeur | - |
Opleiding van Kalle Känd
University of Tartu | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Acino International AG
![]() Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Acino AG
![]() Acino AG Pharmaceuticals: MajorHealth Technology Acino AG engages in the development and manufacture of pharmaceutical products. It also offers services such as registration, procurement, contract manufacturing, packaging, and logistics. Its products include solid oral dosage forms, patches, as well as biodegradable and subcutaneous implants. The company was founded by Wilfried Fischer in 1997 and is headquartered in Miesbach, Germany. | Health Technology |
Acino Supply AG
![]() Acino Supply AG Pharmaceuticals: MajorHealth Technology Acino Supply AG engages in the development, manufacture, purchase, and distribution of pharmaceutical products. It also coordinates all related activities. The company was founded on January 23, 2006 and is headquartered in Aesch, Switzerland. | Health Technology |
Munir Sukhtian Pharmaceuticals
![]() Munir Sukhtian Pharmaceuticals Pharmaceuticals: MajorHealth Technology Munir Sukhtian Pharmaceuticals engages in the manufacturing and distribution of pharmaceuticals. It undertakes marketing and branding of products for infections, obstetrics, gynecology and urinary tract disorders, and cardiovascular and musculoskeletal diseases. The company was founded in 1989 and is headquartered in Amman, Jordan. | Health Technology |